The European interdisciplinary guidelines on the diagnosis and treatment of basal
cell carcinoma (BCC) are a thorough updated and expanded review of the literature
[
[1]
]. The guidelines provide guidance for physicians to optimise BCC care. We strongly
agree with emphasising personalised care and an individualised approach for each patient
and tumour. In addition, we would like to comment on the extensive safety margins
advised for conventional (2D) surgical excision of high-risk BCCs and the proposed
frequent follow-up of patients with a history of BCC.Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to European Journal of CancerAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Diagnosis and treatment of basal cell carcinoma: European consensus-based interdisciplinary guidelines.Eur J Cancer. 2019; 118: 10-34
- The diagnostic accuracy of dermoscopy for basal cell carcinoma: a systematic review and meta-analysis.J Am Acad Dermatol. 2019; 80: 1380-1388
- Guidelines of care for the management of basal cell carcinoma.J Am Acad Dermatol. 2018; 78: 540-559
- The margin of safety and depth of excision in surgical treatment of basalioma. Use of 3-dimensional histologic study of 2,016 tumors.Hautarzt. 1989; 40: 693-700
- A review of the global guidelines on surgical margins for nonmelanoma skin cancers.J Clin Aesthet Dermatol. 2017; 10: 37-46
- Surgical margins for basal cell carcinoma.Arch Dermatol. 1987; 123: 340-344
- Basal cell carcinoma: contemporary approaches to diagnosis, treatment, and prevention.J Am Acad Dermatol. 2018; 80: 321-339
- Nonmelanoma skin cancer and the risk of second primary cancers: a systematic review.Cancer Epidemiol Biomarkers Prev. 2010; 19: 1686-1695
- Predicting the risk of a second basal cell carcinoma.J Investig Dermatol. 2015; 135: 2649-2656
- Surgical excision versus Mohs' micrographic surgery for basal cell carcinoma of the face: a randomised clinical trial with 10 year follow-up.Eur J Cancer. 2014; 50: 3011-3020
- Overall treatment success after treatment of primary superficial basal cell carcinoma: a systematic review and meta-analysis of randomized and nonrandomized trials.Br J Dermatol. 2012; 167: 733-756
- Surgery versus 5% imiquimod for nodular and superficial basal cell carcinoma: 5-year results of the SINS randomized controlled trial.J Investig Dermatol. 2017; 137: 614-619
- Trends in Basal cell carcinoma incidence rates: a 37-year Dutch observational study.J Investig Dermatol. 2013; 133: 913-918
Article info
Publication history
Published online: January 13, 2020
Accepted:
December 4,
2019
Received:
November 29,
2019
Identification
Copyright
© 2019 Elsevier Ltd. All rights reserved.
ScienceDirect
Access this article on ScienceDirectLinked Article
- Diagnosis and treatment of basal cell carcinoma: European consensus–based interdisciplinary guidelinesEuropean Journal of CancerVol. 118
- PreviewBasal cell carcinoma (BCC) is the most common malignant tumour in white populations. Multidisciplinary experts from the European Dermatology Forum, the European Association of Dermato-Oncology and the European Organization of Research and Treatment of Cancer collaborated to develop recommendations on diagnosis and treatment of BCC. A new classification into ‘easy-to-treat (common) BCC and ‘difficult-to-treat’ BCC is proposed. Diagnosis is based on clinicodermatoscopic features for ‘easy-to-treat’ BCCs.
- Full-Text
- Preview
- Comment on ‘Diagnosis and treatment of basal cell carcinoma: European consensus-based interdisciplinary guidelines’European Journal of CancerVol. 131
- PreviewWe thank van Delft et al.[1] for their letter to the Editor related to our published European consensus-based interdisciplinary guidelines on the diagnosis and treatment of basal cell carcinoma (BCC) [2]. They comment on the extensive safety margins for conventional (2D) surgical excision of high-risk BCCs and the proposed frequent follow-up of patients with a history of BCC.
- Full-Text
- Preview
